AMG-9810

AMG-9810
AMG-9810
AMG-9810 Structure.svg
식별자
  • (E)-3-(4-tert-부틸페닐)-N-(2,3-디히드로-1,4-벤조디옥신-6-일)프로프-2-에나미드
CAS 번호
PubChem CID
켐스파이더
유니
체비
첸블
CompTox 대시보드 (EPA )
ECHA 정보 카드100.164.996 Edit this at Wikidata
화학 및 물리 데이터
공식C21H23NO3
몰 질량337.419 g/g−1/g
3D 모델(JSmol)
  • CC(C)(C)C1=CC=C(C=C1)/C=C/C(=O)NC2=CC3=C(C=C2)OCCO3
  • InChI=1S/C21H23NO3/c1-21(2,3)16-7-4-15(5-8-16)6-11-20(23)22-17-9-10-18-19(14-17)25-13-12-24/h4-11,14H,12-13H-13H,12-13H-13,H-13H2
  • 키: GZFUVZVLYUPRG-IZDOVSWSA-N

AMG-9810TRPV1 [1]수용체에 대한 강력하고 선택적인 길항제 역할을 하는 약물이다.진통제, 항염증 효과가 있어 과학 연구에 사용되고 있지만 의학용으로 개발된 것은 아닙니다.그것은 높은 길항제 효력을 가지고 있고 생물학적 가용성약물 동태가 좋으며,[2][3][4][5][6] 따라서 뇌에서의 역할과 같이 통증 지각 이외의 영역에서 TRPV1의 역할을 연구하는데 사용되어 왔다.

「 」를 참조해 주세요.

레퍼런스

  1. ^ Doherty EM, Fotsch C, Bo Y, Chakrabarti PP, Chen N, Gavva N, et al. (January 2005). "Discovery of potent, orally available vanilloid receptor-1 antagonists. Structure-activity relationship of N-aryl cinnamides". Journal of Medicinal Chemistry. 48 (1): 71–90. doi:10.1021/jm049485i. PMID 15634002.
  2. ^ Okun A, DeFelice M, Eyde N, Ren J, Mercado R, King T, Porreca F (January 2011). "Transient inflammation-induced ongoing pain is driven by TRPV1 sensitive afferents". Molecular Pain. 7: 1744-8069–7-4. doi:10.1186/1744-8069-7-4. PMC 3025866. PMID 21219650.
  3. ^ Shirazi M, Izadi M, Amin M, Rezvani ME, Roohbakhsh A, Shamsizadeh A (August 2014). "Involvement of central TRPV1 receptors in pentylenetetrazole and amygdala-induced kindling in male rats". Neurological Sciences. 35 (8): 1235–41. doi:10.1007/s10072-014-1689-5. PMID 24577898. S2CID 24122557.
  4. ^ Amiresmaili S, Shamsizadeh A, Allahtavakoli M, Pourshanazari AA, Roohbakhsh A (February 2014). "The effect of intra-ventral hippocampus administration of TRPV1 agonist and antagonist on spatial learning and memory in male rats". Pharmacological Reports. 66 (1): 10–4. doi:10.1016/j.pharep.2013.06.002. PMID 24905300.
  5. ^ Walters ET (August 2014). "Neuroinflammatory contributions to pain after SCI: roles for central glial mechanisms and nociceptor-mediated host defense". Experimental Neurology. 258: 48–61. doi:10.1016/j.expneurol.2014.02.001. PMID 25017887. S2CID 39671969.
  6. ^ Bannazadeh M, Fatehi F, Fatemi I, Roohbakhsh A, Allahtavakoli M, Nasiri M, et al. (May 2017). "The role of transient receptor potential vanilloid type 1 in unimodal and multimodal object recognition task in rats". Pharmacological Reports. 69 (3): 526–531. doi:10.1016/j.pharep.2017.01.025. PMID 31994094.